chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills/sweats the night after the shot, 101 temp the following morning, chest pain, heaadache.
first dose 3 years ago, never got 2nd dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 3 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 19-Jul-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient never got the 2nd dose of Shingrix. The patient asked that he/she have to start the dosing schedule again. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shngrix, which led to incomplete course of vaccination. The follow-up could not be possible as no contact details were available.
Patient woke with painful shoulder, burning, itching, numbness. Seen by orthopedist, no steroid injection given. Called oncologist office 1/10/17 to report symptoms and asked to come in for assessment. Seen in clinic 1/10/17, and exam clinically consistent with herpes zoster, involving C5 dermatome, not crossing midline. Rash with vesicles noted on exam, some involuted. Treated with famvir and gabapentin, 1st dose of famvir to start 1/10/17.
This spontaneous report as received from a register nurse refers to a patient of unknown age. The patient was vaccinated IM with lot # (666121/0597Z) dose 2, 0.5 ml expired GARDASIL (expired date was 19-AUG-2012) on 28-AUG-2012. Additional information has been requested.
Patient had near syncopal episode w/visual disturbance. Diaphoretic, became hypotensive and bradycardic.
non-DTaP was given to this pt and she is age 11. No adverse events occurred  mom reported 1 d after immunization, pt had 102 fever with headache, lasted 2d, sibling with similar sx. Fever and HA resolved in 2d. No problems since.
patient felt like she was going to faint, but did not.  Transferred by EMS to medical facility.
Approx. 1 hour after receiving vaccine I developed a high fever (102-104) which has persisted. I have had a headache, fever, fatigue, muscle and joint pain, chills, nausea and weakness. In addition the site of the injection is quite sore.
(R) thigh with lump not red not tender. Plan: TYLENOL, MOTRIN, and massage.
Information has been received from a patient with mild psoriasis and questionable irritable bowel disease who was vaccinated with two doses of vaccine 4 weeks apart in April 2000. In approximately October 2000, the patient had titers that showed she did not seroconvert. It was reported that the patient received a third dose subcutaneously in the left upper arm on 02/19/2001. Subsequently, the patient experienced an injection site reaction including swelling and pain that began on 02/20/2001 and lasted for 3 days. The pain was so intense she could not sleep on the side of her body that received the injection. The evening of the vaccine administration the patient developed abdominal pain and nausea. The nausea lasted approximately 12 hours and the abdominal pain lasted about 8 hours. Unspecified medical attention was sought. It was reported the patient recovered.
General Side effects: fatigue, headache, muscle pain, joint pain, chills, nausea and fever. I have experienced all these side effects every day for the last 10 days. Additional side effects are: Sweating profusely every night. Not being able to sleep very well nearly every night. Stomach upset if I eat or if I do not eat. I am only able to eat very bland food since anything else upsets my stomach. I can not drink carbonated beverages since they upset my stomach. As of yesterday I started getting little red sores on my back. This morning it moved to my chest in addition to my back.
Large red erythematous area of 4 inch by 4 inch, very hot to touch, Cellulitis.
Pt had a presyncope episode from the injection. Advised staff he did not eat anything prior to injection.
Headache, chills, fatigue - no treatment - side effects resolved within 24 hours without further complication
Fever, cough, chest congestion and throat congestion (phlegm). Felt better today starting 1/2/2022.
Shingles; Pain behind ear; Rash; Slight dropping in face on the side of vaccination; A spontaneous report was received from consumer concerning a 63 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events- Drooping of Face, Pain Behind Ear, Rash and Shingles.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 13 Feb 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 030MZ0A) intramuscularly for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient noticed that she was experiencing slight dropping in her face on the side of the vaccination. The next day, on 17 Feb 2021, the patient began experiencing some pain behind her ear and a small rash on the same side. She was diagnosed with shingles on 22Feb2021.  Treatment information provided include Allergy Pills, Tylenol, Prednisone, Anti-Bacterial medications.   Action taken with mRNA-1273 in response to the events was not reported.   At the time of this report, the outcome of the event- Drooping of Face, Pain Behind Ear, Rash and Shingles was unknown.; Reporter's Comments: Based on the information provided and a temporal association between the reported events and the administration of mRNA-1273 vaccine, a causal relationship cannot be excluded.
Monitor 9RN) checked on pt at 15 min check.  Pt stated to RN that she was feeling warm, lightheaded and slightly dizzy.  POD leader + supervisor was informed.  Supervisor informed EMS staff of current situation.  Pt was monitored for 15 min more at that time water was given + vitals were taken. BP 140/75, HR 105,SPO2 94% RA & 20 respirations.  09:15 Pt reassessed by (RN) & (EMS), pt showed no changes, and stated that she felt the same.  Pt was removed to a private area to be further evaluated and await until squad arrived.   Pt. also stated to staff that she typically experiences these symptoms whenever she takes in any form of nuts.  Pt stated she does have an epipen injection. 0922 squad arrived. BP 148/90, HR 83, SPO2 99% RA, RR 20.  Pt lung sounds were clear stated by EMS staff.  Pt refused to be rescue by squad/ EMS but instead taken by her husband.  Pt was informed that if anything went wrong on her way to TCH to call 911 right away.  Pt agreed and was discharged at 0921AM.
My lymph nodes are still swollen from the other shots; This spontaneous case was reported by a patient and describes the occurrence of LYMPHADENOPATHY (My lymph nodes are still swollen from the other shots) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Concurrent medical conditions included Breast cancer. Concomitant products included INFLUENZA VACCINE for an unknown indication.   On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (My lymph nodes are still swollen from the other shots). At the time of the report, LYMPHADENOPATHY (My lymph nodes are still swollen from the other shots) had not resolved.      No concomitant medication details reported. Patient got 4 Moderna Covid-19 vaccines and was ready to get the new one. But patient want to know if could get the injection in buttocks. Patient lymph nodes were still swollen from the other shots and just cannot get another one in arm. Patient did not have lymph nodes in arm, so got everything in the other arm. Patient just got flu shot in that arm. No treatment medication details were reported.   Reporter did not allow further contact
Case number PHEH2012US009094, is an initial spontaneous report received from a medical assistant on 26 Apr 2012: This case refers to an 18-years-old male patient. He was received only Men C, Y, W-135 liquid conjugate component of MENVEO vaccine (batch number: X11053) intramuscularly, without reconstituting with Men A component on 26 Apr 2012. No adverse event was occurred during this administration error.
It was reported that a 14 month old male patient received a Trihibit vaccination (combination of Tripedia and ActHIB) on 01/14/00 Reportedly that same day, the patient developed generalized hives, itching and swelling of the eyes and face. The patient was given Benadryl as treatment. From correspondence received 06/13/01 stated that the patient recovered from this experience. This case is closed.
Patient presented to ER with red swollen upper left arm. ? Discomfort as she is non verbal. Suspect cellulitis from recent immunizations. Script for BACTRIM.
CHILLS; TEMPERATURE; This spontaneous report received from a parent concerned a 23 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included factor v. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced chills. On APR-2021, the subject experienced temperature. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and temperature was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Upon leaving after received flu vaccine while walking, became light headed and fell down without any resulting trauma. Pt also did not eat > 12 hours prior. Pt recovered consciousness within 30 seconds without sequelae.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A and expiry: 14/DEC/2021) dose was not reported, administered on DEC-2021 for prophylactic vaccination. No concomitant medications were reported. On DEC-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
Presented to hospital with headache, found to have a large left-sided intracranial hemorrhage and  bilateral occipital intracranial infarcts
This spontaneous report as received from a pharmacist refers to a 54 year old female patient who on 11-MAR-2014, was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (lot number H0119996) that was expired, the patient was vaccinated at health clinic. The vaccine expired on 02-FEB-2014. No adverse effects were reported. Additional information has been requested.
hands blistering & itching started 10JUL or 11JUL seen by MD who prescribed hydroxyzine; DPH cream helped the most;
burning; lost half of her hair; experiencing a bee sting and that it stinging; fall; severe itching; Initial information received on 12-Aug-2021 regarding an unsolicited valid non-serious case received from a consumer (patient).  This case involves a elderly female patient who experienced severe itching (pruritus), burning (burning sensation), lost half of her hair (alopecia), bee sting and that it stinging (pain)and fall, after receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past vaccination(s) included influenza vaccine and no adverse event reported for prophylactic vaccination.  The patient's past medical history, medical treatment(s) and family history were not provided.  At the time of the event, the patient had Osteoporosis.  On an unknown date in 2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious severe itching (pruritus), burning (burning sensation), lost half of her hair (alopecia), bee sting and that it stinging (pain) and fall (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  It was reported that "Caller stated she called a couple of months ago because she had a severe reaction to the FLUZONE HIGH DOSE VACCINE. Caller stated she is still sufferings from it with sever itching and burning. Caller stated she wanted her primary care doctor to give her an exemption card for the COVID-19 shot because they told her if she had a bad reaction to FLUZONE HIGH-DOSE, her COVID-19 reaction would be way worse. Caller is asking what ingredient could cause severe itching and burning in the vaccine. She would like to know who, is it someone at our company, chooses the strains of the inactivated split influenza virus that is in the vaccine. She wants to know if the strains are all from another country. She states that she is miserable and that it is "all over her body". She states that she did not eat anything different so she knows it was the flu shot. She states that she also lost half of her hair and it is not just because of her age and that she knows it was the flu shot. She mentions that she was born in 1934. She states that she can't have anything that would make you dizzy because she "can't handle another fall" and she states that she has osteoporosis. She states that she has no choice and she can not have another vaccine ever again and that she can't even get a tetanus shot. The caller states that she has had an "absolutely miserable year".  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At time of reporting, patient had not recovered from any of the events.  There will be no information available on batch number for this case.
P/inject pt cried & held breath approx 30sec-1min, eyes rolling up & limpness; Mom tried gently shaking child w/no response, no tremors or jerking seen; mild circumoral pallor; Recovered & responsive p/this;
Presented to the Medical Clinic on 8/18/06 with c/o HA, cough, and chest pain with deep breathing times three days. Diagnosed as flu like syndrome from SPV and costochondritis. Orders received for fluids, rest and quarters x 24 hours. Motrin 800mg po tid x 7 days.
Pt vaccinated with Recombivax developed myalgia, rigors, nausea, vomitting, temp 101.6, 12 hrs after 2nd does.
Covid positive. Fever, cough, headache, sinus congestion, nausea.  Taking Tylenol, cough medicine
Significant pain at injection site, increasing overnight so that by morning I couldn't move my arm enough to dress myself, comb hair, etc. Had to miss a day of work. There is still some pain when that arm is lifted or supports weight.
had vaccine on Saturday12/19/20, felt ok and then Sunday night / Monday am she developed a fever and chills. Associate called manager, manager advised associate to call Occ Health. Occ Health sent associate for COVID testing.  Associate is home resting.
Child developed urticaria 48 hours s/p receiving FLUMIST. Patient gave PO BENADRYL. Hives persisted and child was evaluated by MD who Rx'ed Prednisone.
eyes were a little bit swollen; it is a little itchy; congestion; being sneezing a lot; This is a spontaneous report from a contactable consumer (Patient). A 35-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO1TO), via an unspecified route of administration on 07May2021 (at the age of 35 years old) as a single dose for COVID-19 immunisation. The patient's medical history included Seasonal allergy, Prediabetes from an unknown date and unknown if ongoing. The patient's concomitant medication included Prempro (ESTROGENS CONJUGATED, MEDROXYPROGESTERONE ACETATE) taken for hormones and start date and stop date was not reported. On an unspecified date of May-2021 the patient experienced eyes were a little bit swollen, Itchy, congestion, being sneezing a lot. The patient reported that her eye got too it was like its swollen but in two different parts like lid and then patient's upper eye lid and in the eye lid area and like patient was telling (name), patient did not know she got the vaccine on 07May it was a friday. So on Monday night patient noticed two swollen spots on eye. The patient was napping so she was not sure when that happened. Patient was washing face when Patient noticed swelling of the eye. The patient had tend to have seasonal allergy, it was just during spring and during fall time. So like the patient was telling (name) yesterday patient had Tylenol for my allergy but patient was calling to make sure she could take Zyrtec because this is something new the vaccine. The patient did not know if the patient could take over the counter medication so that's why patient called this number in the web page. The patient did not receive any treatment for events. The outcome of the events was unknown.  Follow-up(11May2021): This is a follow-up spontaneous report from a contactable consumer included Relevant medical history was added, Patient information updated, Product details were added and Concomitant drugs were added.  Follow-up attempts are completed. No further information is expected.
Swollen lymph node in arm where shot was administered; This is a spontaneous report from a non-contactable consumer (patient).   A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose on arm for covid-19 immunisation.  The patient medical history was not reported.     The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation.  The patient experienced swollen lymph node in arm where shot was administered on an unspecified date with outcome of unknown.  Was given antibiotics. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
7pm the same night experienced chills 8-9pm that night body aches, joint pain, hot feeling with no fever Whole day Sunday: severe joint pain, body aches, and headache Lasted until today. Only symptom today is joint pain
Initial COVID-19 infection prior to Paxlovid treatment; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Initial COVID-19 infection prior to Paxlovid treatment) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939904) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 24-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced COVID-19 (Initial COVID-19 infection prior to Paxlovid treatment). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 13-May-2022 to 18-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (Initial COVID-19 infection prior to Paxlovid treatment) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. patient was not other medications/products within 2 weeks of starting COVID-19 treatment. Patient had relapse of covid 5 days after finishing paxlovid. Became symptomatic again and tested positive again on antigen test on 22-May-2022.  Treatment medication information was not provided.  Company Comment:  This is a spontaneous case concerning a 47-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious adverse event of special interest COVID-19, described as initial COVID-19 infection prior to Paxlovid treatment, which occurred approximately 7 months after receiving a dose of mRNA-1273 as the third dose of COVID-19 vaccine (no information disclosed on previous COVID-19 vaccinations). Patient was given a six-day-course of Paxlovid treatment for the initial COVID-19 infection. However, four days after the treatment with Paxlovid, patient became symptomatic again, then tested positive for COVID-19 antigen. Outcome of the event for the initial COVID-19 infection was unknown. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 47-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious adverse event of special interest COVID-19, described as initial COVID-19 infection prior to Paxlovid treatment, which occurred approximately 7 months after receiving a dose of mRNA-1273 as the third dose of COVID-19 vaccine (no information disclosed on previous COVID-19 vaccinations). Patient was given a six-day-course of Paxlovid treatment for the initial COVID-19 infection. However, four days after the treatment with Paxlovid, patient became symptomatic again, then tested positive for COVID-19 antigen. Outcome of the event for the initial COVID-19 infection was unknown. The benefit-risk relationship of mRNA-1273 is not affected by this report.
pt recv vax & devel an inj site rxn characterized by redness & swelling the size of a fifty cent piece;
Information has been received from a registered nurse concerning a patient who on 06-APR-2000 was vaccinated with a dose of Varivax. Subsequently, on 15-MAR-2006, the patient developed breakthrough varicella. Unspecified medical attention was sought. There was no product quality complaint. No additional information is expected.
Starting the 10th,  patient has had bad headache, severe muscle pains more than usual, SOB more than normal and severe fatigue.  She thought it would go away but the symptoms got worse with each day. No fever. She  had been taking Ibuprofen and Tylenol around the clock. Symptoms had  not improved Also had been nauseated since Monday 4-12-21. The site was sore and her arm felt heavy and she could hardly lift it.
Cellulitis -itching at site stared 7pm on 1/12/21 worsening to right elbow pain and widening area of redness and swelling . Treatment sought on 1/14/21 started 7 day course of doxycycline. Still experiencing slight redness at site and arm pain including elbow joint pain. Symptoms getting better.
He was taking ibuprofen 200 mg two tablets, every 4 hours. The fever went down, and the pains in the body were reduced, currently he still feels it in less intensity.